Insights

Gathering insights about Aileron Therapeutics…

Similar companies to Aileron Therapeutics

Aileron Therapeutics Tech Stack

Aileron Therapeutics uses 8 technology products and services including Typekit, Google Cloud, React, and more. Explore Aileron Therapeutics's tech stack below.

Typekit
Font Scripts
Google Cloud
Infrastructure As A Service
React
Javascript Frameworks
Underscore.js
Javascript Libraries
New Relic
Real User Monitoring
X-XSS-Protection
Security
Acquia Cloud Site Factory
Web Hosting
Nginx
Web Servers

Media & News

Aileron Therapeutics's Email Address Formats

Aileron Therapeutics uses at least 1 format(s):

Aileron Therapeutics Email Formats	Example	Percentage
FLast@aileronrx.com	JDoe@aileronrx.com	48%
FirstL@aileronrx.com	JohnD@aileronrx.com	2%
FLast@aileronrx.com	JDoe@aileronrx.com	48%
FirstL@aileronrx.com	JohnD@aileronrx.com	2%

Frequently Asked Questions

Where is Aileron Therapeutics's headquarters located?

Aileron Therapeutics's main headquarters is located at 285 Summer Street Boston, MA 02210 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Aileron Therapeutics's phone number?

You can contact Aileron Therapeutics's main corporate office by phone at

+1-617-995-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aileron Therapeutics's stock symbol?

Aileron Therapeutics is a publicly traded company; the company's stock symbol is ALRN.

What is Aileron Therapeutics's official website and social media links?

Aileron Therapeutics's official website is aileronrx.com and has social profiles on LinkedIn.

What is Aileron Therapeutics's SIC code NAICS code?

Aileron Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aileron Therapeutics have currently?

As of September 2024, Aileron Therapeutics has approximately 15 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer Treasurer Secretary: C. G.Chief Financial Officer: D. D.Vice President Quality Assurance: K. L.. Explore Aileron Therapeutics's employee directory with LeadIQ.

What industry does Aileron Therapeutics belong to?

Aileron Therapeutics operates in the Biotechnology Research industry.

What technology does Aileron Therapeutics use?

Aileron Therapeutics's tech stack includes TypekitGoogle CloudReactUnderscore.jsNew RelicX-XSS-ProtectionAcquia Cloud Site FactoryNginx.

What is Aileron Therapeutics's email format?

Aileron Therapeutics's email format typically follows the pattern of . Find more Aileron Therapeutics email formats with LeadIQ.

How much funding has Aileron Therapeutics raised to date?

As of September 2024, Aileron Therapeutics has raised $20M in funding. The last funding round occurred on May 01, 2024 for $20M.

When was Aileron Therapeutics founded?

Aileron Therapeutics was founded in 2005.

Aileron Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Following the acquisition of Lung Therapeutics in October 2023, Aileron is shifting its disease focus to advancing a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis diseases, including LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusion (LPE). For more information about the company, please visit our website.

Company Overview

Headquarters: 285 Summer Street Boston, MA 02210 US
Phone number: ✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-995-****
Website: aileronrx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ALRN
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2005
Employees: 11-50

Media & News

Funding & Financials

$20M
Aileron Therapeutics has raised a total of $20M of funding over 12 rounds. Their latest funding round was raised on May 01, 2024 in the amount of $20M.

Funding & Financials

$20M
Aileron Therapeutics has raised a total of $20M of funding over 12 rounds. Their latest funding round was raised on May 01, 2024 in the amount of $20M.

Company Leadership

C. G.
Chief Financial Officer Treasurer Secretary
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. D.
Chief Financial Officer
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. L.
Vice President Quality Assurance
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. P.
Head Of Intellectual Property
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. W.
President And Chief Executive Officer
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. Z.
Vice President, Program Management And Clinical Operations
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. L.
Vice President Quality Assurance
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. R. C.
Vp Of Finance
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. P.
Head Of Intellectual Property
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. V.
Senior Vice President
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aileron Therapeutics and Millions of Other Companies
Sign up for full access to Aileron Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Aileron Therapeutics

Athenex

Agios Pharmaceuticals

Blueprint Medicines

Atara Biotherapeutics

Mersana Therapeutics

Ikena Oncology

Aileron Therapeutics Tech Stack

Media & News

Aileronrx hired Timothy M. Cunningham as interim chief financial officer on May 16th '24.

Aileronrx hired Brian Windsor as President and Chief Executive Officer on Mar 11th '24.

Aileronrx launches interim analysis, highlighting that ALRN-6924.

Aileronrx acquired Lung Therapeutics, Inc. on Nov 1st '23.

Aileronrx received financing of $56M in IPO on Jan 1st '17.

Aileronrx is developing ALRN-6924 on May 17th '22.

Wanstall leaves Aileronrx as Chief Financial Officer and Treasurer.

Aileron Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Aileron Therapeutics's headquarters located?

What is Aileron Therapeutics's phone number?

What is Aileron Therapeutics's stock symbol?

What is Aileron Therapeutics's official website and social media links?

What is Aileron Therapeutics's SIC code NAICS code?

How many employees does Aileron Therapeutics have currently?

What industry does Aileron Therapeutics belong to?

What technology does Aileron Therapeutics use?

What is Aileron Therapeutics's email format?

How much funding has Aileron Therapeutics raised to date?

When was Aileron Therapeutics founded?

Aileron Therapeutics

Company Overview

Media & News

Aileronrx hired Timothy M. Cunningham as interim chief financial officer on May 16th '24.

Aileronrx hired Brian Windsor as President and Chief Executive Officer on Mar 11th '24.

Aileronrx launches interim analysis, highlighting that ALRN-6924.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?